Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cost-driven revolution in diabetes management ahead

This article was originally published in Clinica

Executive Summary

A needlestick-free treatment regime awaits sufferers of diabetes in the coming decade, says a new report from Theta Reports, part of PJB Publications (see p 26 of this issue), says. Advancing technology and cost-containment pressures will likely see the end of both hypodermic insulin injections and finger-prick glucose monitoring, predicts The Future of Diabetes Diagnostics: Monitoring & Management in 2010.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT064574

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel